, /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP).
The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground. Efforts will focus on critical needs including infection prevention, hygiene support, community-based health services and emergency food assistance— areas where speed and adaptability can directly save lives.
Together, Save the Children, IRC and WFP bring complementary capabilities and deep operational presence to coordinate response efforts in some of the most affected communities. Their combined expertise allows resources to be directed quickly to where they are needed most as the situation continues to evolve.
"The Ebola outbreak is occurring in a highly fragile humanitarian environment, where years of underinvestment and recent global funding cuts have severely weakened health services," said Heather Reoch Kerr, IRC's Country Director for the Democratic Republic of Congo. "The IRC has extensive experience responding to Ebola and other infectious disease outbreaks in complex humanitarian settings. The support from the Danaher Foundation is critical to continue the IRC's response to the Ebola outbreak."
"This generous support comes at a critical moment for communities in eastern DRC," said Barron Segar, President and CEO of World Food Program USA. "Containing Ebola requires speed, coordination and access, and this grant will help WFP move life-saving medical cargo, transport frontline responders and provide families affected by the outbreak with food assistance to help prevent this health crisis from sparking a deeper hunger emergency."
"The Ebola outbreak is compounding an already dire humanitarian crisis in the DRC," said Greg Ramm, Save the Children's Country Director in the Democratic Republic of Congo. "For children, the stakes could not be higher—they urgently need access to basic healthcare and protection. We are deeply grateful for Danaher's partnership. Their support will help us deliver essential medical supplies, strengthen efforts to contain the spread of the disease, and ultimately save lives."
According to the World Health Organization (WHO), more than 1,000 cases of Ebola Bundibugyo have been confirmed in the Democratic Republic of Congo, with cases now spreading to neighboring Uganda. Fewer than half of infections are currently diagnosed and traced, suggesting the outbreak may be larger than reported. Children under the age of 14 are particularly vulnerable and more than twice as likely to die after contracting Ebola.
ABOUT EBOLA DISEASE
The Centers for Disease Control (CDC) defines Ebola as a disease caused by an infection with an orthoebolavirus found primarily in sub-Saharan Africa. Orthoebolaviruses can cause serious and often deadly disease, with a mortality rate as high as 80-90 percent. The 2026 Ebola outbreak is driven by the Bundibugyo virus disease (BVD), that causes a severe and often fatal form of Ebola disease. Declared a Public Health Emergency of International Concern by the WHO, the 2026 outbreak is historically the largest known Bundibugyo virus outbreak.
ABOUT THE DANAHER FOUNDATION
The Danaher Foundation is the independent philanthropic arm of Danaher Corporation, a global life sciences and technology innovator. Through partnerships with trusted nonprofit organizations and communities around the world, the Foundation's work reflects Danaher's broader commitment to applying science, innovation, and collaboration to address urgent global needs.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
Pedestrians approach a Union Pacific freight train traveling past Jack London Square, Oakland, California, April 26, 2026. (Photo by Smith Collection/Gado/Getty Images)
Gado via Getty Images
The proposed merger of Union Pacific and Norfolk Southern is about life and death. Yes, you read that right. Which requires a brief digression.
Specifically, to Hillary Clinton versus Donald Trump in 2016. Remember when partisans of both claimed the election would decide whether the U.S. went the way of Venezuela, or not?
Life or death in politics is generally a fraud, though it’s a device used by politicians and partisans alike. Elect me or my candidate to “save” the people from all manner of horrors. It’s nonsense, and it should be treated as such.
Still, with transportation it’s not partisan or emotional to say that trucks on U.S. roads bring with them a body count. Over 5,000 deaths, most of them for innocents not driving trucks, in 2023 alone.
Please keep the trucking-related deaths top of mind while reading about the ongoing, Washington-driven delays of the proposed Union Pacific merger with Norfolk Southern. Yes, there’s a death count associated with the shipment of market goods by trucks that the merger addresses. That’s because the annual body count associated with rail shipment is near non-existent.
None of which is an unwarranted attack on trucking as a mode of shipment. The latter is essential as evidenced by the fact that over three quarters of market good shipments in the U.S. are handled by trucks.
MORE FOR YOU
Just the same, and in the dominance of trucking as a mode of shipment, it’s easy to see that the would-be combination of Union Pacific and Norfolk Southern in no way creates what’s impossible to create in a free market: a national rail monopoly. And it certainly wouldn’t create a shipping monopoly. See the previously mentioned dominance of trucking.
What the merger would create is crucial information. Specifically, how much healthier and competitive rail networks would be if they could combine their efforts and resources on the path to more seamless national, and eventually international rail networks. Knowledge like this is particularly pressing right now.
To see why, readers need only contemplate the growth of wealth around the United States at all income levels. As Peggy Noonan observed in a recent column, sometimes we need to see what we’ve grown used to seeing through the eyes of others.
Noonan was alluding to the awestruck reactions of visitors to North America, and the U.S. specifically, for the World Cup. The consensus has been that they’re very taken by just how enormously well Americans live.
How this applies to goods shipment is that as wealth grows, so will grow the movement of goods around the United States. Yes, consumption mirrors production and production stateside will continue to soar. Which means advances in goods shipment must be achieved sooner rather than later not to bring harm to the trucking industry, but to avoid the necessity of not just more trucks on roads populated with passenger vehicles, but much bigger ones.
The proposed combination of Union Pacific and Norfolk Southern is ultimately an endeavor meant to discover whether rail, through fixed intercontinental routes, can shoulder what will be growing amounts of shipment throughout the United States and beyond. The answer to the latter must be discovered simply because if railroads aren’t the answer, others must be found.
As you read this, there’s a movement afoot in Washington to bring bigger, heavier, and longer trucks to America’s highways. To say that the delay of Union Pacific/Norfolk Southern is associated with these political machinations is hardly an insight. Which is tragic, along with a reminder that politics in Washington sometimes has a body count.
Morgan Stanley (MS - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this investment bank have returned +1.9%, compared to the Zacks S&P 500 composite's -2.9% change. During this period, the Zacks Financial - Investment Bank industry, which Morgan Stanley falls in, has gained 7.4%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Morgan Stanley is expected to post earnings of $2.73 per share for the current quarter, representing a year-over-year change of +28.2%. Over the last 30 days, the Zacks Consensus Estimate has changed +1%.
The consensus earnings estimate of $11.81 for the current fiscal year indicates a year-over-year change of +15.7%. This estimate has changed -0.4% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $12.36 indicates a change of +4.7% from what Morgan Stanley is expected to report a year ago. Over the past month, the estimate has changed -0.9%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Morgan Stanley is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Morgan Stanley, the consensus sales estimate for the current quarter of $18.86 billion indicates a year-over-year change of +12.3%. For the current and next fiscal years, $77.04 billion and $80.22 billion estimates indicate +9% and +4.1% changes, respectively.
Last Reported Results and Surprise HistoryMorgan Stanley reported revenues of $20.58 billion in the last reported quarter, representing a year-over-year change of +16%. EPS of $3.43 for the same period compares with $2.6 a year ago.
Compared to the Zacks Consensus Estimate of $19.85 billion, the reported revenues represent a surprise of +3.7%. The EPS surprise was +12.09%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Morgan Stanley is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Morgan Stanley. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Intuit (INTU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Key Takeaways Reliance shares rose 33.5% year to date, outperforming the industry's 14.7% rise. Reliance sold 1.673M tons in Q1'26, marking a 13th straight quarter of industry outperformance. AMI Metals won border wall contracts, while demand stayed strong across key industrial markets. Reliance, Inc.’s (RS - Free Report) shares have rallied 33.5% year to date. The company has also outperformed the Zacks Mining - Miscellaneous industry’s 14.7% growth over the same time frame. The rally was driven by strong first-quarter results, including record quarterly tons sold, with shipments outperforming industry trends.
Image Source: Zacks Investment Research
Let’s take a look at the factors that are driving RS stock.
Growth Strategy & Demand Strengthen Market Position for RSReliance reported first-quarter 2026 tons sold of roughly 1.673 million, up 9.4% sequentially and 2.7% year over year, marking its 13th consecutive quarter of outperforming industry shipment trends.
The company continues to benefit from strong demand in non-residential construction, driven by public infrastructure, heavy civil construction, data centers, energy infrastructure and manufacturing projects.
Through its AMI Metals subsidiary, Reliance secured major Department of Homeland Security border wall contracts expected to support future revenue growth. Demand also remained healthy across automotive toll processing, semiconductors, defense, shipbuilding, industrial machinery and nuclear-related markets, particularly those tied to small modular reactor programs.
Reliance continues to strengthen its growth profile through acquisitions that expand its geographic footprint, product offerings and value-added processing capabilities. Earlier acquisitions, such as Metals USA, Tubular Steel, Best Manufacturing, Ferguson, All Metals, Fry Steel Company and Merfish United, enhanced its service center network and higher-margin product mix.
Recent acquisitions, including Rotax, Admiral Metals, Nu-Tech Precision Metals, Southern Steel Supply, Cooksey Iron & Metal Co. and American Alloy, further increase its presence in attractive U.S. growth markets.
The company ended the quarter with $249.7 million in cash and cash equivalents, up from $216.6 million sequentially, supported by record shipment volumes and strong profitability.
Reliance's growth momentum appears well supported by a combination of strong end-market demand, disciplined capital allocation and strategic acquisitions. Record shipment volumes, a diversified exposure to resilient sectors such as infrastructure, aerospace, defense and data centers, along with a healthy balance sheet, position the company to sustain growth. As infrastructure spending and manufacturing investments remain, the stock is likely to maintain its positive momentum over the coming quarters.
RS’s Zacks Rank & Other Key PicksRS currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the Basic Materials space include Nucor Corporation (NUE - Free Report) , L.B. Foster Company (FSTR - Free Report) and Albemarle Corporation (ALB - Free Report) . NUE, FSTR and ALB carry a Zacks Rank of #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for NUE’s current-year earnings stands at $17 per share, implying a 120.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the average surprise being 8.1%. Shares of the company have surged around 47% year to date.
The Zacks Consensus Estimate for FSTR’s current-year earnings is pegged at $1.74 per share, implying a 152.2% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in one of the trailing four quarters and missed thrice, with the average surprise being 3.62%. Shares of FSTR have surged around 66.1% year to date.
The Zacks Consensus Estimate for ALB’s current-year earnings is pegged at $12.98 per share, indicating a 1,743% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average surprise being 74.5%. Shares of ALB have plunged around 5.5% year to date.
Broadcom’s (NASDAQ: AVGO) next dividend is coming tomorrow, June 30, as the semiconductor and infrastructure software company continues its sixteen-year payout streak.
More specifically, Broadcom will reward its shareholders as of June 22 with $0.65 per share, keeping its payout unchanged from the previous quarter, as per DivvyDiary figures.
In other words, investors holding 100 AVGO shares can expect a Broadcom stock dividend payment of $65 tomorrow, which should bring their year-to-date income to $130.
At this rate, the total yearly payouts will amount to $260. However, since it started paying dividends in 2010, the firm has consistently increased the payout each year, so additional increases are likely by year-end.
Broadcom dividends calendar. Source: DivvyDiary Broadcom currently offers a forward dividend yield of about 0.74% (below the industry average of 1.37%), with an annual forward payout of $2.74 per share. This positions it more as a dividend growth company than a traditional income stock.
Indeed, this year’s total returns highlight how performance is still overwhelmingly driven by price appreciation, not dividends. For example, DivvyDiary data shows that a hypothetical $10,000 investment made at the start of 2026 would have grown to roughly $10,688 with dividends reinvested.
Of the total gain, $656 would have come from price appreciation, while only $32 would be generated by dividends. That means dividends contributed a small fraction of overall returns in this period.
On an annualized basis, the total return is shown at 14.55%, even though the simple total return stands at 6.89% over the period measured. This reflects the combination of price growth and reinvested dividends compounding modestly over time.
Judging by the Broadcom dividend history, the stock usually recovers in approximately 7 to 9 days following the ex-dividend dip.
Featured image via Shutterstock
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
Record Q2 EarningsBroadcom kicked off the month with its fiscal Q2 2026 results on June 3. Revenue hit $22.19 billion, up 48% year-over-year, but came in slightly below the $22.27 billion consensus estimate. Earnings per share of $2.44 beat the $2.40 consensus. AI semiconductor revenue surged 143% year-over-year to $10.8 billion, driven by increasing demand for custom AI accelerators and AI networking.
The Jalapeño RevealOn June 24, Broadcom and OpenAI unveiled Jalapeño—OpenAI’s first custom AI inference chip. Broadcom handled the silicon implementation, networking, and connectivity technologies, while OpenAI designed the architecture around its deep understanding of LLM inference needs. The chip went from initial design to manufacturing tape-out in just nine months, potentially the fastest ASIC development cycle ever achieved in high-performance semiconductors.
Early testing shows Jalapeño will deliver performance per watt substantially better than current state-of-the-art alternatives, with initial deployment targeted for the end of 2026 at gigawatt scale with Microsoft and other data center partners.
The PullbackDespite the beat on earnings per share beat, record AI revenue and the Jalapeño reveal, Broadcom is down approximately 20% this month. The revenue miss, the strategic pivot away from integrated AI systems and questions about the stock’s premium valuation may all be contributing factors.
Broadcom Shares Edge HigherAVGO Price Action: At the time of publication, Broadcom shares are trading 2.19% higher at $373.00, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
This is a fair market value price provided by Massive. Learn more.
52-Week Range$262.66▼
$495.00Dividend Yield0.72%
P/E Ratio60.61
Price Target$493.24
Semiconductor giant Broadcom NASDAQ: AVGO experienced a dramatic drop-off since its last earnings report. Just days prior to the release, Broadcom traded at its all-time high near $480. However, the company failed to meet the extremely high expectations implied by its valuation, and shares tanked almost 20% in the following two days.
Amid this, one Wall Street firm coming to Broadcom’s defense is JPMorgan Chase & Co. The bank and its analyst, Harlan Sur, have a $580 price target on Broadcom. This is among the highest on Wall Street and far exceeds the MarketBeat consensus target near $493.
Get Broadcom alerts:
Notably, Sur recently reiterated his highly bullish target on Broadcom. Sur also provided key commentary for his rationale that paints a very positive picture of Broadcom’s relationship with its most important customer.
Broadcom and Alphabet: The Hot Button TPU DebateOne of the concerns coming out of Broadcom’s last earnings call was the future of its relationship with Google parent company Alphabet NASDAQ: GOOGL. Alphabet is widely believed to be Broadcom’s largest custom artificial intelligence (AI) chip customer.
The two firms have collaborated on multiple generations of Alphabet’s tensor processing units (TPUs) for several years. This is a core partnership that has helped Broadcom become the world’s second-largest semiconductor company, only behind NVIDIA NASDAQ: NVDA. Thus, when thinking about Broadcom’s outlook, investors are keenly aware of anything that points to volatility in its relationship with Alphabet.
In this context, a quote from Broadcom CEO Hock Tan from the company’s last earnings call was somewhat troubling. Tan noted, “Given the growth of consumption and development and consumption of AI compute, even by our partner, Google, that we fully expect that there will be some diversity of sources for them.” In other words, Google’s TPU program is becoming so large that Broadcom does not expect to be the only partner involved with it going forward.
Notably, industry analysts believe that the Taiwanese company MediaTek OTCMKTS: MDTKF is also a TPU partner. However, analysts debate the size of this partnership and the specific TPU variants that MediaTek is working on.
JPMorgan Shows Confidence in Broadcom’s TPU LeadershipConsidering this, JPMorgan’s analysis is positive for Broadcom. Currently, Google is on its eighth generation TPU, TPU v8, which features multiple variants. JPMorgan says that the five-year agreement that Google and Broadcom signed in March “locks in Broadcom’s TPU design win roadmap for the next four generations of TPU chips through v11.” JPMorgan also believes this means that Broadcom’s TPU revenues will increase annually through 2031. Furthermore, JPMorgan argues that investors should dismiss reports of delays in the TPU v9 program, saying that TPU v9 is on track to ramp up in 2028.
This pushes back on other reporting that Broadcom’s TPU v9 progress is facing delays. These reports argue that Broadcom has “lost its leading position," which has allowed MediaTek to win major orders for the TPU v9.
For its part, JPMorgan is showing a fairly significant amount of confidence that Broadcom remains in pole position within Google’s TPU program. The firm demonstrates this by reiterating its $580 target—a level that many Wall Street targets sit well below.
Additionally, there is real disagreement around MediaTek’s specific involvement with Google. JPMorgan argues that Broadcom is developing the inference-optimized TPU v8i, while MediaTek is working on the training-optimized TPU v8t. Other industry reports point to MediaTek designing the v8i and Broadcom designing the v8t.
Beyond the Rumors: Broadcom’s AI Chip Business Continues to ExplodeFor investors, there are several key takeaways. First off, reports among these various sources contradict one another. This is true regarding potential delays with Broadcom’s TPU v9 and which variants Broadcom and MediaTek are working on in the TPU v8. Thus, at this point, it is best to focus on facts and the points of general consensus.
Overall MarketRank™100th Percentile
Analyst RatingModerate Buy
Upside/Downside35.1% Upside
Short Interest LevelHealthy
Dividend StrengthStrong
News Sentiment1.17 Insider TradingSelling Shares
Proj. Earnings Growth71.97%
See Full Analysis
Broadcom has been working with Google for a long time. Broadcom expects its AI semiconductor revenue to rise by over 200% year over year next quarter to $16 billion. Meanwhile, just months ago, Google and Broadcom entered a long-term agreement for Broadcom to develop and supply future generations of TPUs. In its fiscal year 2027, Broadcom expects to generate more than $100 billion in AI semiconductor revenue.
However, all cited reports state that MediaTek is also involved in TPU development. Hock Tan did little to push back on this with its recent statement. MediaTek also recently raised its custom AI chip revenue forecast in 2026 to $2 billion. It estimates that this market will be worth $70 billion to $80 billion in 2027. The company is targeting 10% to 15% of that total in the coming years, implying an opportunity well above $2 billion. Still, Broadcom’s AI chip business is far larger today and is growing extremely fast.
Overall, with limited clarity today, the relationship between Google, Broadcom, and MediaTek is a risk to watch going forward, but not worth the panic. In the meantime, one of Wall Street’s top banks, JPMorgan, is calling for Broadcom shares to eclipse previous all-time highs by $100.
Should You Invest $1,000 in Broadcom Right Now?Before you consider Broadcom, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Broadcom wasn't on the list.
While Broadcom currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
NEW YORK & SANTA CLARA, Calif.--(BUSINESS WIRE)--Accenture (NYSE: ACN) and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today launched a joint offering with two core components: managed security services built on the ServiceNow AI Platform and an Accenture AI-powered solution that automates migration from legacy systems to ServiceNow. Together, Accenture and ServiceNow are removing two of the biggest barriers blocking enterprise risk modernization: cost and complexity.
Coinbase Global, Inc. (COIN - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this company have returned -21.2% over the past month versus the Zacks S&P 500 composite's -2.9% change. The Zacks Financial - Miscellaneous Services industry, to which Coinbase Global belongs, has lost 3.5% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Coinbase Global is expected to post earnings of $0.31 per share, indicating a change of +158.3% from the year-ago quarter. The Zacks Consensus Estimate has changed -23% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $1.74 points to a change of -56.8% from the prior year. Over the last 30 days, this estimate has changed -9%.
For the next fiscal year, the consensus earnings estimate of $4.53 indicates a change of +160.6% from what Coinbase Global is expected to report a year ago. Over the past month, the estimate has changed +2.6%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Coinbase Global is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Coinbase Global, the consensus sales estimate of $1.38 billion for the current quarter points to a year-over-year change of -7.6%. The $6.06 billion and $7.22 billion estimates for the current and next fiscal years indicate changes of -15.6% and +19.1%, respectively.
Last Reported Results and Surprise HistoryCoinbase Global reported revenues of $1.41 billion in the last reported quarter, representing a year-over-year change of -30.5%. EPS of -$0.17 for the same period compares with $1.94 a year ago.
Compared to the Zacks Consensus Estimate of $1.5 billion, the reported revenues represent a surprise of -5.61%. The EPS surprise was -147.22%.
Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates just once over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Coinbase Global is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Coinbase Global. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
SAN DIEGO, June 29, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Roblox Corporation (NYSE: RBLX) common stock between October 30, 2025 and April 30, 2026, inclusive (the “Class Period”), have until Friday, August 7, 2026 to seek appointment as lead plaintiff of the Roblox class action lawsuit. Captioned Mukherjee v. Roblox Corporation, No. 26-cv-05489 (N.D. Cal.), the Roblox class action lawsuit charges Roblox and certain of Roblox’ top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Roblox class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
CASE ALLEGATIONS: Roblox operates as a global video gaming and social networking company.
The Roblox class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Roblox’ bookings growth expectations and the overall anticipated impact from the age verification rollout while also minimizing risks associated with the rollout and its potential knock-on effects; (ii) Roblox misled investors when discussing tailwinds resulting from the age verification process while continuing to be “enormously bullish” on their tech rollouts as well as claiming to be able to “rely on [their] tremendous organic growth”; and (iii) Roblox relied far too heavily on viral events to drive growth and failed to communicate to investors the potential knock-on impacts of the age verification rollout, including how it could impact the platform’s ratings, engagement, and overall public perception.
On April 30, 2026, Roblox announced its 2026 first quarter results, allegedly reporting declines in revenue guidance and projected annual bookings growth, as well as reductions in communication engagement, app store ratings, and organic sign-ups as a result of the age verification rollout. On this news, the price of Roblox stock fell more than 18%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Roblox common stock during the Class Period to seek appointment as lead plaintiff in the Roblox class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Roblox class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Roblox class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Roblox class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
WYOMISSING, Pa.--(BUSINESS WIRE)--PENN Entertainment, Inc. (Nasdaq: PENN) announced today that it will release its 2026 second quarter financial results at 7:00 a.m. ET on Thursday, August 6, 2026, followed by a conference call and simultaneous webcast at 9:00 a.m. ET. Both the call and webcast are open to the general public. The conference call number is 833-309-3473 (conference ID: PENN); please call five minutes in advance to ensure that you are connected prior to the presentation. Intereste.
Strategy shares are climbing with conviction. What’s driving MSTR stock higher? The Digital Credit Capital Framework has five components: a Board-approved USD Reserve policy, a revised STRC dividend policy, a Digital Credit Securities repurchase program of up to $1 billion, a class A common stock repurchase program of up to $1 billion, and a BTC Monetization Program. The announcement marks a meaningful strategic evolution, from one-way capital issuance toward active, two-way capital management.
The USD ReserveThe STRC Dividend and Repurchase ProgramsStrategy raised the dividend rate on its Variable Rate Series A Perpetual Stretch Preferred Stock to 12.00% annually, effective for semi-monthly periods with record dates on or after July 1, 2026. The company said its corporate objective is for STRC to trade near its $100 stated amount over time.
On the repurchase side, Strategy established a $1 billion program covering its Digital Credit Securities, including STRC, STRF, STRD, and STRK, with STRC expected to be the initial priority. A separate $1 billion class A common stock repurchase program was also announced.
The BTC Monetization ProgramThe Board authorized Strategy to sell Bitcoin for three primary purposes: to generate up to $1.25 billion to fund the USD Reserve, to fund preferred stock dividends and interest expense when management determines it is more advantageous than issuing equity, and to fund repurchases of Digital Credit Securities or common stock. Any BTC monetization outside these purposes requires additional Board authorization.
“Bitcoin is capital,” said Andrew Kang, CFO. “This program gives Strategy the flexibility to use a portion of its BTC Reserve to strengthen Digital Credit, fund dividend payments and interest expense, and fund accretive repurchases when BTC monetization is more advantageous than issuing common equity.”
Strategy Shares Trade HigherMSTR Price Action: At the time of publication, Strategy shares are trading 4.04% higher at $85.63, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Strategy Inc. MSTR shares (previously known as MicroStrategy) rose 2.7% in trading on Monday after the company announced a broad capital management overhaul.
The plan aims to strengthen liquidity, support its preferred securities, and maintain long-term exposure to Bitcoin.
The announcement follows a period of pressure on the company's valuation.
Strategy's market capitalisation had fallen below the value of its Bitcoin holdings, causing its market-cap-to-Bitcoin-net-asset-value ratio to slip below one.
The development prompted criticism from market participants who questioned the sustainability of the company's capital model.
Strategy said the new framework represents a shift in how it manages its capital structure.
The plan includes a $1 billion preferred securities repurchase programme, a separate $1 billion Class A common stock buyback programme, a structured Bitcoin monetisation programme, a revised dividend policy for STRC preferred stock, and a formal USD Reserve policy.
Chief Executive Officer Phong Le said the company is "evolving from one-way capital issuance to active capital management."
Founder Michael Saylor said the framework is "designed to strengthen credit quality and enable the Company to reduce expected preferred stock dividend payments when accretive."
Strategy said its USD Reserve stood at approximately $2.55 billion as of June 28, 2026.
Under the newly approved board policy, those funds may only be used to support preferred stock dividend payments and interest on outstanding debt.
The company has established a minimum reserve requirement equal to 12 months of annual preferred stock dividends and interest expenses, representing approximately $1.76 billion.
When combined with $1.25 billion of board-authorised Bitcoin monetisation capacity, Strategy said total preferred stock dividend liquidity coverage reaches approximately $3.80 billion, or around 25.9 months of coverage.
As part of the framework, Strategy increased the dividend rate on its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) to 12% annually.
The higher rate will apply to semi-monthly periods with record dates on or after July 1, 2026.
The company said its objective is for STRC to trade close to its stated value of $100 over time.
Strategy also established a $1 billion repurchase programme covering its Digital Credit Securities, including STRC, STRF, STRD and STRK, with STRC expected to receive initial priority.
A separate $1 billion Class A common stock repurchase programme was announced alongside the preferred securities buyback.
The board also authorised a structured Bitcoin monetisation programme.
Under the programme, Strategy may sell Bitcoin for three approved purposes.
These include generating up to $1.25 billion to support the USD Reserve, funding preferred stock dividends and interest expenses when management determines selling Bitcoin is more advantageous than issuing equity, and financing repurchases of Digital Credit Securities or common stock.
The company said any Bitcoin monetisation outside these approved purposes would require additional board authorisation.
Chief Financial Officer Andrew Kang said, "Bitcoin is capital. This program gives Strategy the flexibility to use a portion of its BTC Reserve to strengthen Digital Credit, fund dividend payments and interest expense, and fund accretive repurchases when BTC monetization is more advantageous than issuing common equity."
Chubb (CB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Block & Leviton LLP announces that the United States District Court for the District of Massachusetts has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Biogen, Inc. (NASDAQ: BIIB):
OKLAHOMA FIREFIGHTERS PENSION AND
RETIREMENT SYSTEM, Plaintiff,
v.
BIOGEN INC., MICHEL VOUNATSOS, AND
ALISHA ALAIMO,
Defendants.
Case No. 22-cv-10200-WGY
CLASS ACTION
SUMMARY NOTICE OF PROPOSED
SETTLEMENT OF CLASS ACTION
TO:ALL PURCHASERS AND ACQUIRERS OF BIOGEN INC. COMMON STOCK BETWEEN JUNE 8, 2021 AND JULY 12, 2021, INCLUSIVE
A Federal Court has authorized this notice. This is not a solicitation from a lawyer.
Please read this notice carefully. An $18.9 million settlement has been reached for investors in Biogen Inc. common stock between June 8, 2021 and July 12, 2021.
if you are a member of the Class, your legal rights will be affected whether you act or not.
Notice of Settlement: You are hereby notified that a hearing will be held on September 29, 2026, at 2:00 p.m., before the Honorable William G. Young, at the United States District Court, District of Massachusetts, John Joseph Moakley U.S. Courthouse, 1 Courthouse Way, Boston, MA 02210, Courtroom 18 – 5th Floor, to determine whether:
(1) the proposed settlement (the “Settlement”) of the above-captioned Action as set forth in the Stipulation and Agreement of Class Action Settlement, dated June 5, 2026 (“Stipulation”) for $18.9 million in cash should be approved by the Court as fair, reasonable, and adequate;
(2) the Judgment as provided under the Stipulation should be entered dismissing the Action with prejudice;
(3) to award Lead Counsel attorneys’ fees and expenses out of the Settlement Fund (as defined in the Notice of Proposed Settlement of Class Action (“Notice”), which is discussed below) and, if so, in what amounts;
(4) to award Lead Plaintiff expenses pursuant to 15 U.S.C. §78u-4(a)(4) in relation to their representation of the Class out of the Settlement Fund and, if so, in what amount; and
(5) the Plan of Allocation should be approved by the Court as fair, reasonable, and adequate.
It is possible that the Court may decide to change the date and/or time of the Settlement Hearing, conduct the Settlement Hearing by video or telephonic video conference, or otherwise allow Class Members to appear at the hearing by telephone or video conference, without further written notice to the Class. To determine whether the date and time of the Settlement Hearing have changed, or whether Class Members must or may participate by telephone or video, it is important that you monitor the Court’s docket and the website, www.BiogenSecuritiesLitigation.com, for any update before making any plans to attend the Settlement Hearing.
IF YOU PURCHASED OR ACQUIRED BIOGEN INC. (“BIOGEN”) COMMON STOCK BETWEEN JUNE 8, 2021 AND JULY 12, 2021, INCLUSIVE, YOUR RIGHTS MAY BE AFFECTED BY THE SETTLEMENT OF THIS LITIGATION
Proof of Claim: To share in the distribution of the Net Settlement Fund, you must establish your rights by submitting a Proof of Claim and Release form (“Proof of Claim”) by mail (postmarked no later than September 24, 2026) or electronically via the website (no later than 11:59 ET on September 24, 2026). Failure to submit your Proof of Claim by September 24, 2026 will subject your claim to rejection and preclude you from receiving any of the recovery in connection with the Settlement of this Action.
If you purchased or acquired Biogen common stock during the period between June 8, 2021 and July 12, 2021, inclusive, and do not request exclusion from the Class, you will be bound by the Settlement and any judgment and release entered in this Action, including, but not limited to, the Judgment, whether or not you submit a Proof of Claim.
Notice: The Notice, which more completely describes the Settlement and your rights thereunder (including your right to object to the Settlement), the Proof of Claim, the Stipulation (which, among other things, contains definitions for the defined terms used in this Summary Notice), and other important documents, may be accessed online at www.BiogenSecuritiesLitigation.com, or by writing to or calling:
Biogen Securities Litigation Settlement
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Ste. 205
Media, PA 19063
1-866-274-4004
Inquiries should NOT be directed to Defendants, the Court, or the Clerk of the Court. Inquiries other than requests for the Notice or for a Proof of Claim may be made to Lead Counsel:
Block & Leviton LLP
Michael D. Gaines
260 Franklin Street, Suite 1860
Boston, MA 02110
(617) 398-5600 [email protected]
Exclusion: If you desire to be excluded from the Class, you must submit a request for exclusion such that it is received by August 25, 2026, in the manner and form explained in the Notice. All Class members will be bound by the Settlement even if they do not submit a timely Proof of Claim.
Objections: If you are a Class member, you have the right to object to the Settlement, the Plan of Allocation, the request by Lead Counsel for an award of attorneys’ fees, and/or the request for an award to Lead Plaintiff in connection with its representation of the Class. Any objections must be filed with the Court and sent to Lead Counsel and Defendants’ counsel such that they are received by September 8, 2026, in the manner and form explained in the Notice available at www.BiogenSecuritiesLitigation.com.
June 16, 2026By Order of the Court
United States District Court, District of Massachusetts
Biogen (BIIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Affirm Holdings (AFRM - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of this operator of digital commerce platform have returned +7.9% over the past month versus the Zacks S&P 500 composite's -2.9% change. The Zacks Internet - Software industry, to which Affirm Holdings belongs, has lost 5.2% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Affirm Holdings is expected to post earnings of $0.36 per share for the current quarter, representing a year-over-year change of +80%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The consensus earnings estimate of $1.25 for the current fiscal year indicates a year-over-year change of +733.3%. This estimate has changed +0.6% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $1.69 indicates a change of +35.8% from what Affirm Holdings is expected to report a year ago. Over the past month, the estimate has changed -0.6%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Affirm Holdings is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Affirm Holdings, the consensus sales estimate of $1.1 billion for the current quarter points to a year-over-year change of +26%. The $4.21 billion and $5.33 billion estimates for the current and next fiscal years indicate changes of +30.6% and +26.5%, respectively.
Last Reported Results and Surprise HistoryAffirm Holdings reported revenues of $1.04 billion in the last reported quarter, representing a year-over-year change of +32.6%. EPS of $0.3 for the same period compares with $0.01 a year ago.
Compared to the Zacks Consensus Estimate of $997.92 million, the reported revenues represent a surprise of +4.09%. The EPS surprise was +76.47%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Affirm Holdings is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Affirm Holdings. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
New "Fit Checks" campaign embeds cancer risk education directly into a wearable design to make early detection part of everyday life
, /PRNewswire/ -- Aflac, a pioneer and leader in cancer insurance for seven decades, today announced the launch of Fit Checks, an innovative new awareness campaign developed with fashion designer Rachel Zoe, transforming a familiar pattern into an interactive pathway to understanding cancer risk and educating on the importance of screenings.
Aflac Check for Cancer
Aflac X Rachel Zoe At the center of the campaign is a first-of-its-kind garment designed by Rachel Zoe that features a custom checkered pattern with a QR code seamlessly integrated into the design, turning everyday fashion into a health activation tool. The limited-edition garment, when scanned, connects consumers directly to CheckForCancerNow.com, a new website dedicated to increasing awareness of the value of cancer screenings.
"For too many people, cancer screenings remain something they'll get around to when it is convenient," said Virgil Miller, president, Aflac Incorporated and Aflac U.S. "Fit Checks is designed to change that by driving awareness from an unexpected place: the clothes we wear. By partnering with well-known designer and media star Rachel Zoe, we're creating a new way to meet people in unexpected places with a powerful message, spark action and make conversations about early detection a part of everyday life."
The campaign comes at a time when too many Americans continue to delay preventive care. According to the 2025 Aflac Wellness Matters Survey, roughly 3 in 5 Americans (59%) admit to avoiding important health screenings, while 9 in 10 Americans (94%) say they have delayed a checkup or recommended health screening. These findings reinforce the urgent need to make early detection more approachable, accessible and actionable.
"Fashion has always been a way for people to express themselves, but it can also be a powerful way to break through in culture and start important conversations," said Rachel Zoe. "What drew me to this campaign was the opportunity to create something that feels stylish and meaningful at the same time. If fashion can inspire people to check for cancer, we are making fashion not only wearable but purposeful as well."
To kick off Aflac's partnership with Zoe, the company has released, on social media, a brief video previewing the anticipated campaign which launches later this year, showing how her newly designed garment will signal a broader plea to encourage potentially lifesaving cancer screenings. Consumers can take the first step toward understanding their cancer risk by visiting CheckForCancerNow.com to learn more about early detection and why it is so important to check for cancer.
"Fashion occupies a unique place in culture, creating opportunities to reach people beyond traditional settings. Through Fit Checks, Aflac, a leading provider of cancer insurance in the United States and Japan, is leveraging that cultural relevance to make cancer awareness more visible, and to drive action," Miller said.
Fit Checks is part of Aflac's broader Check for Cancer movement, which aims to associate the checkered patterns people see every day with a movement to increase cancer screenings. The goal is to increase screenings in the U.S. by 10% over the next 10 years.
To learn more, visit www.CheckForCancerNow.com.
FAQs about the Check for Cancer initiative and Fit Checks campaign
What does Check for Cancer mean?
Check for Cancer is a national movement created by Aflac to help increase cancer screenings in the U.S. by 10% over 10 years. By transforming the checkered pattern into a powerful call to action, the movement helps encourage people to prioritize cancer screenings, because early detection can save lives.
At its core, Check for Cancer is about making cancer screenings a more visible and urgent priority, helping people learn about their risks, understand recommended screenings and take action earlier. Why is early detection so important?
Cancer can affect anyone. One in three people will be diagnosed with cancer in their lifetime, but when found early, many cancers have five-year survival rates above 90%.
That is why Aflac is encouraging people to learn about their risks and prioritize recommended screenings. The earlier cancer is found, the more options people may have and the better their chances of a positive outcome. What is Fit Checks?
Fit Checks is a Check for Cancer awareness campaign designed to help make cancer screening more urgent, accessible and hard to ignore. By leveraging fashion as a powerful vehicle to turn awareness into action, Fit Checks transforms the checkered pattern into a purposeful prompt to check for cancer. In partnership with celebrity fashion designer Rachel Zoe, Aflac created a first-of-its-kind garment with a QR code embedded in the print, making it easy for people to learn about their cancer risk on the spot. ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force.2 The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune's World's Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."
1 LIMRA 2025 U.S. Supplemental Health Insurance Total Market Report
2 As of March 31, 2025, Aflac estimates based on company data
Media contact: Darcy Brito, 706-505-9762 or [email protected]
Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or [email protected]
Aflac WWHQ | 1932 Wynnton Road | Columbus, GA 31999
Aflac New York | 22 Corporate Woods Boulevard, Suite 2 | Albany, New York 12211
Continental American Insurance Company | Columbia, SC
Key Takeaways DuPont analysis breaks ROE into margins, efficiency and leverage to reveal true strength.Screening found five picks: CASY, ECG, GRDN, EXPD and MAMA with solid fundamentals.Strong earnings surprises and healthy DuPont metrics signal potential upside ahead. Return on equity (ROE) is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend in companies and compare this to historical or industry benchmarks to pick a winning stock.
However, stepping beyond the basic ROE and analyzing it at an advanced level could lead to even better returns. Here is where the DuPont analysis comes into play. It is an analytical method that examines three major elements – operating management, management of assets and the capital structure – related to the financial condition of a company. Below, we show how DuPont breaks down ROE into its different components:
ROE = Net Income/Equity
Net Income / Equity = (Net Income / Sales) * (Sales / Assets) * (Assets / Equity)
The screener yields winning stocks like Casey's General Stores (CASY - Free Report) , Everus Construction Group Inc. (ECG - Free Report) , Guardian Pharmacy Services Inc. (GRDN - Free Report) , Expeditors International of Washington (EXPD - Free Report) and Mama's Creations Inc. (MAMA - Free Report) .
Why Use DuPont?Although one can’t play down the importance of normal ROE calculation, the fact remains that it doesn’t always provide a complete picture. The DuPont analysis, on the other hand, allows investors to assess the elements that play a dominant role in any change in ROE. It can help investors to segregate companies with higher margins from those having a high turnover. For example, high-end fashion brands generally survive on high margins as compared with retail goods, which rely on higher turnover.
In fact, it also sheds light on the company’s leverage status, which can go a long way in selecting stocks poised for gains. A lofty ROE could be due to the overuse of debt. Thus, the strength of a company can be misleading if it has a high debt load.
So, an investor confined solely to an ROE perspective may be confused if he or she has to judge between two stocks with equal ratios. This is where DuPont analysis wins over and spots the better stock.
Investors can simply do this analysis by taking a look at the company’s financials.However, looking at the financial statements of each company separately can be a tedious task. Screening tools like Zacks Research Wizard can come to your rescue and help you shortlist the stocks that look impressive with a DuPont analysis.
Screening Parameters• Profit Margin more than or equal to 3: As the name suggests, it is a measure of how profitably the business is running. Generally, it is the key contributor to ROE.
• Asset Turnover Ratio more than or equal to 2: It allows an investor to assess management’s efficiency in using assets to drive sales.
• Equity Multiplier between 1 and 3: It’s an indication of how much debt the company uses to finance its assets.
• Zacks Rank less than or equal to 2: Stocks having a Zacks Rank #1 (Strong Buy) or 2 (Buy) generally perform better than their peers in all types of market environments.
• Current Price more than $5: This screens out the low-priced stocks. However, when looking for lower-priced stocks, this criterion can be removed.
Here are five out of 11 stocks that made it through the screen:
Casey's General Stores: The Zacks Rank #1 company operates convenience stores primarily under the Casey's and Casey's General Store names in 19 states, mainly Iowa, Missouri and Illinois. You can see the complete list of today’s Zacks #1 Rank stocks here.
The average earnings surprise of CASY for the past four quarters is 18.40%.
Everus Construction Group: The Zacks Rank #1 company is providing a full spectrum of construction services through its electrical and mechanical, and transmission and distribution specialty contracting services principally in the United States.
The average earnings surprise of ECG for the past four quarters is 61.97%.
Guardian Pharmacy Services:The Zacks Rank #2 company is a long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term healthcare facilities.
The average earnings surprise of GRDN for the past four quarters is 16.65%.
Expeditors International of Washington: The Zacks Rank #1 company is a leading third-party logistics provider.
The average earnings surprise of EXPD for the past four quarters is 13.96%.
Mama's Creations: The Zacks Rank #2 company manufactures and distributes fresh deli-prepared foods sold through more than 12,000 grocery, mass, club and convenience stores across the United States.
The average earnings surprise of MAMA for the past four quarters is 129.17%.
LOS ANGELES--(BUSINESS WIRE)---- $GTM--ZoomInfo Technologies Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – GTM.
DraftKings (DKNG - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this company have returned +4.9%, compared to the Zacks S&P 500 composite's -2.9% change. During this period, the Zacks Gaming industry, which DraftKings falls in, has gained 5.7%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, DraftKings is expected to post earnings of $0.34 per share, indicating a change of -10.5% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $1.15 points to a change of +74.2% from the prior year. Over the last 30 days, this estimate has remained unchanged.
For the next fiscal year, the consensus earnings estimate of $1.78 indicates a change of +54.4% from what DraftKings is expected to report a year ago. Over the past month, the estimate has remained unchanged.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, DraftKings is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For DraftKings, the consensus sales estimate for the current quarter of $1.57 billion indicates a year-over-year change of +3.9%. For the current and next fiscal years, $6.8 billion and $7.77 billion estimates indicate +12.4% and +14.2% changes, respectively.
Last Reported Results and Surprise HistoryDraftKings reported revenues of $1.65 billion in the last reported quarter, representing a year-over-year change of +16.8%. EPS of $0.2 for the same period compares with $0.12 a year ago.
Compared to the Zacks Consensus Estimate of $1.64 billion, the reported revenues represent a surprise of +0.12%. The EPS surprise was -9.09%.
Over the last four quarters, DraftKings surpassed consensus EPS estimates times. The company topped consensus revenue estimates two times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
DraftKings is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about DraftKings. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
FuelCell Energy stock is among today’s top performers. What’s driving FCEL stock higher? FCEL Stock Rises on $49 Million Government Loan ApprovalThe clean energy technology company announced that the Export-Import Bank of the United States (EXIM) Board of Directors approved a $49 million financing package on June 23. The financing, structured under EXIM’s loan guarantee program alongside the Private Export Funding Corporation, will be disbursed in two tranches.
The first tranche is expected to disburse on June 30, providing FuelCell Energy with approximately $22 million in net proceeds. These funds will support the delivery of five 2.8-megawatt FuelCell Energy Blocks to Gyeonggi Green Energy in South Korea. A second tranche is anticipated in October 2026, subject to customary closing conditions.
“EXIM’s approval validates the strength of this project, our partnership with Gyeonggi Green Energy, FuelCell Energy’s business plan, and our ability to deliver distributed utility-scale clean power globally,” said Michael Bishop, FuelCell Energy’s Chief Financial Officer.
How Broader Market Trends Impact FCEL StockIndustrials momentum provides a benchmark for FuelCell Energy because the stock has been trading like a momentum industrial/energy hybrid, and it was recently up 25.41% to $24.64 with a market cap around $1.3 billion in a market cap stands snapshot of Friday’s intraday movers.
Critical Price Levels To Watch For FCELThe bigger-picture trend remains firmly bullish: at $26.50, the stock is trading 30.6% above its 20-day SMA ($20.24) and 157.9% above its 200-day SMA ($10.25), which is the kind of separation you typically only see in momentum-led runs. That distance also raises the odds of sharper pullbacks if buyers pause, because there’s a lot of "air" down to the faster moving averages.
From a structure standpoint, the 20-day SMA is above the 50-day SMA (bullish), and the 50-day SMA is above the 200-day SMA—confirming the golden-cross regime that began in October 2025. The stock also logged a recent swing high in May and a swing low in April, so the current push is happening after a higher-low type setup.
For momentum, MACD is the cleaner read right now: it’s above its signal line and the histogram is positive, which points to improving upside pressure versus the prior downswing. In plain terms, when MACD is above the signal line, it suggests buyers are regaining control of the trend rather than just bouncing.
Key Resistance: $27.50 — a nearby ceiling just below the $27.69 52-week high zone where breakouts can stall
What Is FuelCell Energy and Its Business Model?FuelCell Energy is a clean energy technology company that develops, designs, produces, and services high-temperature fuel cells used for clean electric power generation. Its core platform is proprietary molten carbonate fuel cell systems that generate electricity electrochemically, aiming for ultra-low emissions and high efficiency.
The company also acts as a solutions provider—handling design, manufacturing, installation, and maintenance—often under long-term power purchase, service, and engineering procurement agreements. That matters for the Fit Energy announcement because data centers tend to value reliable, on-site baseload power, and the agreement’s milestone-based path (from 30 MW toward 380 MW) fits the way large infrastructure deployments typically scale.
FuelCell Energy’s latest leg higher is also being shaped by the Street recalibrating expectations after Jefferies moved its target to $24 from $16, a reset that followed the 380 MW headline and helped extend the rally described in charging ahead with momentum.
FuelCell operates across the United States, South Korea, Europe, and Canada, with the United States as its largest revenue source. If the data-center channel continues to open up, it can influence both utilization of planned capacity and investor confidence in the company’s targeted scale to 500 MW.
FCEL Earnings Preview and Analyst RatingsLooking further out, the next major catalyst for the stock arrives with the September 8, 2026 (estimated) earnings report.
EPS Estimate: Loss of 37 cents (Up from a loss of 95 cents YoY) Revenue Estimate: $38.59 million (Down from $46.74 million YoY) Analyst Consensus & Recent Actions: The stock carries a Hold rating with an average price target of $18.83 (high: $30.00; low: $8.00) across 8 analysts. Recent analyst moves include:
UBS: Neutral (Raises Target to $22.00) (June 26) Jefferies: Upgraded to Buy (Raises Target to $24.00) (June 26) Wells Fargo: Underweight (Raises Target to $8.00) (June 16) FCEL Stock Price Movement During PremarketFCEL Stock Price Activity: FuelCell Energy shares were up 10.75% at $26.58 during premarket trading on Monday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure helps cut through all the noise.
The earnings figure itself is key, of course, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa.
Hunting for 'earnings whispers' or companies poised to beat their quarterly earnings estimates is a somewhat common practice. But that doesn't make it easy. One way that has been proven to work is by using the Zacks Earnings ESP tool.
The Zacks Earnings ESP, ExplainedThe Zacks Earnings ESP is more formally known as the Expected Surprise Prediction, and it aims to grab the inside track on the latest analyst estimate revisions ahead of a company's report. The idea is relatively intuitive as a newer projection might be based on more complete information.
With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure. The system also utilizes our core Zacks Rank to provide a stronger system for identifying stocks that might beat their next quarterly earnings estimate and possibly see the stock price climb.
Bringing together a positive earnings ESP alongside a Zacks Rank #3 (Hold) or better has helped stocks report a positive earnings surprise 70% of the time. Furthermore, by using these parameters, investors have seen 28.3% annual returns on average, according to our 10 year backtest.
Stocks with a ranking of #3 (Hold), or 60% of all stocks covered by the Zacks Rank, are expected to perform in-line with the broader market. Stocks with rankings of #2 (Buy) and #1 (Strong Buy), or the top 15% and top 5% of stocks, respectively, should outperform the market; Strong Buy stocks should outperform more than any other rank.
Should You Consider Lam Research?Now that we understand what the ESP is and how beneficial it can be, let's dive into a stock that currently fits the bill. Lam Research (LRCX - Free Report) earns a #3 (Hold) right now and its Most Accurate Estimate sits at $1.70 a share, just 30 days from its upcoming earnings release on July 29, 2026.
LRCX has an Earnings ESP figure of +3.09%, which, as explained above, is calculated by taking the percentage difference between the $1.70 Most Accurate Estimate and the Zacks Consensus Estimate of $1.65. Lam Research is one of a large database of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
LRCX is part of a big group of Computer and Technology stocks that boast a positive ESP, and investors may want to take a look at Yelp (YELP - Free Report) as well.
Slated to report earnings on August 6, 2026, Yelp holds a #3 (Hold) ranking on the Zacks Rank, and its Most Accurate Estimate is $0.36 a share 38 days from its next quarterly update.
For Yelp, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $0.33 is +8.43%.
LRCX and YELP's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.
Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Workday (WDAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Considering buying CRWD stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Qualys (QLYS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Toyota Motor (TM) reported its fourth straight monthly sales decline in May, as weakness in China and the Middle East outweighed stronger demand at home in Japa
Hyundai activated across BETX FanFest, the BET Awards Red Carpet and BET's Icon of the Year Award honoring actress Teyana Taylor , /PRNewswire/ -- Hyundai Motor America today announced its first-ever sponsorship of the BET Awards and BET Experience 2026, which marked a new partnership with one of entertainment's most influential celebrations of Black culture, music, creativity and achievement.
Hyundai marks First-Ever Sponsorship of the BET Awards and BET Experience 2026. Photo credit: Mad Works Photography. "Hyundai is proud to have been part of culture's biggest night and to have debuted as a sponsor of the BET Awards and BET Experience," said Randy Parker, president and CEO, Hyundai Motor North America. "Teyana Taylor's impact on culture is undeniable. Her creativity across music, fashion and film reflects what it looks like to move with vision, purpose and originality. At Hyundai, we believe the future starts now, and we are honored to celebrate artists and innovators who continue to help drive culture forward."
Hyundai Debuted as an Integrated Partner Across BET Awards Weekend
Hyundai's BET Awards weekend sponsorship included three core integrations: presenting sponsorship of the BETX Main Stage at FanFest, vehicle integration during the BET Awards Red Carpet and Digital Pre-Show, and sponsorship of BET's Icon of the Year Award honoring Teyana Taylor during the live broadcast.
"The BET Awards and BET Experience bring community, culture, and connection together like nothing else in the media landscape. It's where fans, artists, and brands show up to all share the biggest moments in Black culture," said Louis Carr, president, BET.
Hyundai Presented the BETX Main Stage at BET Experience FanFest
Hyundai served as presenting sponsor of the BETX Main Stage Presented by Hyundai during BET Experience FanFest, which took place June 26-27 at The Beehive in South Los Angeles. As one of the weekend's major fan destinations, FanFest brought together music, community, food and culture through live performances and immersive experiences.
Mariah the Scientist headlined Saturday's programming, with additional talent across the FanFest lineup including B2K, Coi Leray, Destin Conrad, Fabolous, G Herbo, Jaewon, kwn and Larry June.
Hyundai's presence at FanFest included vehicle integrations throughout the festival footprint, creating opportunities for fans to engage with the brand in a high-energy, culture-forward environment.
Hyundai Vehicles Were Featured During the BET Awards Red Carpet and Digital Pre-Show
On Sunday, June 28, Hyundai was featured as part of the BET Awards Red Carpet and Digital Pre-Show, one of the weekend's most visible moments.
The integration featured the Hyundai Santa Fe, IONIQ 9, and Palisade with co-branded visuals across the pre-show and BET's digital platforms. Elements included celebrity interview moments, vehicle visuals, digital livestream presence and social content captured throughout the red carpet experience.
Hyundai Sponsored BET's Icon of the Year Award Honoring Teyana Taylor
Hyundai also served as sponsor of BET's Icon of the Year Award, which honored Teyana Taylor during the BET Awards 2026 live broadcast on Sunday, June 28. The award celebrates an artist who is defining the cultural moment through their work, presence, vision and influence. BET announced Taylor as the recipient of BET's Icon of the Year Award sponsored by Hyundai on June 9, 2026.
Taylor, a multi-hyphenate creative force, has built an expansive career across music, film, fashion, directing, choreography and producing. From Harlem to the global stage, her work reflects a distinctive creative vision and an undeniable impact on culture. As part of the integration, Parker appeared in a pre-recorded video segment recognizing Taylor and connecting Hyundai's support to the broader celebration of artistry, creativity and cultural impact. BET's Icon of the Year Award sponsorship also included co-branded category graphics during the live broadcast, digital extensions and social content recognizing Taylor.
Partnership Reflects Hyundai's Commitment to Culture, Community and Innovation
The BET Awards, known as "Culture's Biggest Night," recognizes excellence across music, film, television, sports and philanthropy. Hyundai's first year as a sponsor reflects the brand's commitment to showing up in culturally meaningful ways and creating experiences that connect design, innovation and mobility with the artists and audiences shaping what's next.
"This partnership is about more than visibility. It is about showing up with intention," said Erik Thomas, director, experiential and multicultural marketing, Hyundai Motor America. "Through music, storytelling and live experiences, Hyundai is proud to be part of a weekend that celebrates creativity, community and cultural momentum."
The BET Awards Aired on Sunday, June 28, 2026, from Los Angeles
The BET Awards 2026 aired live on Sunday, June 28, 2026, at 8 p.m. ET/PT from the Peacock Theater in Los Angeles, with Druski as host.
ABOUT BET MEDIA GROUP
The BET Media Group, a unit of Paramount, a Skydance Corporation (Nasdaq: PSKY), is the world's largest media company rooted in community, culture, and connection for the Black community. For over four decades, BET has served as a trusted home for Black audiences, amplifying authentic stories, elevating Black voices, and creating spaces where culture thrives and community comes together.
Through a powerful portfolio of brands—including BET, BET Her, BET Studios, and VH1—along with FAST channels such as BET Tyler Perry Comedy, BET Tyler Perry Drama, BET Comedy Movies, BET Cinema, BET Classics, BET Visionaries, BET Throwbacks, and BET Pluto, BET connects audiences across cable, digital, live events, studios, and global platforms. Together, these platforms deliver culturally resonant content that reflects the depth, creativity, and impact of the Black experience. For more information, visit www.bet.com and follow @BET on social platforms. For additional announcements, visit paramountpressexpress.com/bet/.
ABOUT BET AWARDS
"BET Awards" is one of the most-watched award shows on cable television, according to the Nielsen Company. The "BET Awards" franchise remains the #1 program in cable TV history among African-Americans, and it is the #1 telecast for BET every year. It recognizes the triumphs and successes of artists, entertainers, and athletes in a variety of categories.
ABOUT BET EXPERIENCE
BET Experience is the destination for elevating unapologetic Blackness with authentic entertainment, access, and lifestyle experiences. Through the lens of millennial and Gen Z audiences, BET Experience curates the culture, standing at the intersection of who this coveted segment is and where they're headed.
Hyundai Motor America
Hyundai Motor America offers U.S. consumers a technology-rich lineup of cars, SUVs, and electrified vehicles, while supporting Hyundai Motor Company's Progress for Humanity vision. Hyundai has significant operations in the U.S., including its North American headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, several cutting-edge R&D facilities and more than 855 independent dealers. These operations are part of Hyundai Motor Group, which is investing $26 billion in the U.S. from 2025 to 2028. For more information, visit www.hyundainews.com.
Hyundai Motor America on Twitter | YouTube | Facebook | Instagram | LinkedIn | TikTok
After recovering nearly 20% from June 5 lows, Robinhood (NASDAQ: HOOD) stock received two new positive recommendations on the penultimate day of the month.
The first of the two came in the form of a 12-month HOOD price upgrade from $108 to $121 from Goldman Sachs’ (NYSE: GS) James Yaro, who, simultaneously, rated the equity as a ‘Buy’.
According to the analyst, Robinhood reported stronger-than-anticipated activity through June, with preliminary data showing a rocket in activity across multiple asset types – cryptocurrencies, stocks, options, and event contracts – thus backing the upgrade.
Additionally, Yaro’s estimate is that the data reinforces the view that the platform’s growth, product rollout, and a rise in retail investment activity are all driving momentum.
Elsewhere, though Barclays analyst Benjamin Budish also issued a ‘Buy’ recommendation for Robinhood stock, he nonetheless chose to keep the previous – and comparatively bearish, as it constitutes a 16.91% downside – $82 price target for the next 12 months.
Analysts predict Robinhood stock price in the next 12 months Zooming out, despite remaining 14.34% in the red year-to-date (YTD) at their latest closing price of $98.69, HOOD shares command Wall Street optimism. Specifically, Robinhood is, overall, considered a ‘Strong Buy’ on the stock analysis platform TipRanks, per the data Finbold retrieved on June 29.
Notably, the figures appear to reflect the equity’s 38% rise in the previous two months as, in contrast to the decisive recommendation, it is expected to rally only 5.50% to $104.12 in the next 12 months on average.
Wall Street sets Robinhood stock price for the next 12 months. Source: TipRanks 2026 Robinhood stock price chart Indeed, after starting the year trading at $115.21, Robinhood stock entered a downtrend that led it more than 43% lower to roughly $65 by late March. HOOD shares’ performance since has not been entirely decisive, as it featured multiple rapid rallies, followed by steep corrections.
Robinhood stock price YTD chart. Source: Google Thus, despite the equity rising almost 40% in the last two months and 19.67% since the June 5 lows, Robinhood remains 8% under the $108 high recorded only ten days earlier, even at its June 29 extended session press-time price of $100.35.
Featured image via Shutterstock
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Rocket Lab (NASDAQ: RKLB) stock price has suffered a major reversal in the past few weeks, moving from the year-to-date high of $151 on May 27 to $84. This retreat continued even after the company landed a new NASA contract last week. So, is it safe to buy the dip or sell the rip?
RKLB share price has dropped sharply in the past few weeks as investors booked profits following its spectacular rally ahead of the SpaceX IPO. It jumped to a record high of $151, up by 3,700% from its lowest level in 2014, with its market capitalization peaking at $82 billion.
The ongoing Rocket Lab stock retreat has coincided with that of other companies in the space industry. SpaceX itself has plunged by over 30% from its highest point after its IPO. Also, other top players in the space industry, like Planet Labs and Intuitive Machines, have also plunged recently.
The sell-off intensified recently after the company entered the blue-chip index, a move that forced ETF and mutual fund operators to buy it. It is common for stocks to pop after an ETF inclusion news and then retreat when it eventually happens.
Most importantly, demand for Rocket Labs’ solutions jumped after NASA selected the company for the Polarized Submillimeter Ice-cloud Radiometer (PolSIR) and Total and Spectral Solar Irradiance Sensor-2 (TSIS-2) missions. The deal is worth $300 million.
Rocket Lab’s growth is continuing, but valuation risks remainThe most recent financial results showed that Rocket Labs’ business is firing on all cylinders with the number of launches continuing growing. It made a record $200 million revenue, up by 63.5% from the same period last year. Also, the company’s revenue backlog surged to over $2.2 billion or 70+ missions.
While most of these orders are for its Electron product, the company is seeing more demand for its HASTE and Neutron projects. It secured 5 Neutron launches in the last quarter, with the manifest filling to end of the decade.
Analysts predict that Rocket Lab’s revenue growth will continue in the foreseeable future. The annual revenue is expected to be $915 million, up by 52% YoY. It is expected to grow by 41% next year to $1.29 billion.
Still, there are concerns about the company’s valuation, which has become extremely stretched in the past few months. It now trades with a forward price-to-sales ratio of 53, which is a massive number. This means that it will need to continue growing its revenues and boosting its profit metrics in the long term.
READ MORE: Here’s why Rocket Lab stock is ripe for a strong comeback
Rocket Lab stock chart | Source: TradingView
The daily chart shows that the RKLB share price has dived in the past few months, moving from a high of $151 to $84 today. Its current price is notable as it coincides with the ascending trendline that connects the lowest swings since November last year.
The stock remains above the 200-day Exponential Moving Average (EMA), a sign that all hope is not lost. It has also settled along the Strong, Pivot, Reverse level of the Murrey Math Lines tool.
Therefore, there is a likelihood that the Rocket Lab stock price will bounce back and retest the Major S&R level of $100 as investors buy the dip. This view will become invalid if the stock drops below the Strong, Pivot, Reverse level of the Murrey Math Lines at $75.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The commercial space industry is entering a new phase. Simply reaching orbit is no longer enough to build a durable business. The companies likely to create the most shareholder value over the next decade are those that control more of the space economy — from designing satellites and launching them to operating the communications networks those satellites power.
SpaceX (NASDAQ:SPCX) demonstrated the power of that strategy with Falcon and Starlink. Now Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has taken a major step in the same direction, announcing an acquisition that could reshape its business for years to come.
Rocket Lab Is Buying More Than a Satellite Company Rocket Lab announced it will acquire Iridium Communications (NASDAQ:IRDM) in an $8 billion cash-and-stock transaction expected to close in mid-2027. Iridium shareholders will receive $27 in cash plus Rocket Lab shares for each Iridium share they own.
Funding such a large transaction naturally raises monetary questions, and Rocket Lab also announced it secured a $3.6 billion bridge loan, giving it the financing needed to complete the acquisition while arranging longer-term capital.
The acquisition will create one of the few publicly traded companies spanning launch services, satellite manufacturing, spacecraft components, and global satellite communications.
That changes Rocket Lab’s economic model. Instead of relying primarily on one-time launch contracts, it gains a business built around subscription-like connectivity services for commercial customers, governments, maritime operators, aviation, and direct-to-device applications.
The acquisition also creates operational advantages as Neutron enters service. Rocket Lab would be positioned to launch future generations of Iridium satellites using its own rocket rather than purchasing launch services from outside providers. Keeping those launches in-house lowers expenses across the satellite replacement cycle while giving Rocket Lab greater control over scheduling and deployment.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
That mirrors the strategy that has helped SpaceX widen its competitive lead. Combining launch capability with ownership of the communications network allows a company to manage costs across the entire value chain instead of paying outside providers at every stage.
The Space Economy Is Becoming a Platform Business The competitive landscape is also changing. Some companies will specialize in building spacecraft or selling launch services. Others will own integrated platforms that design satellites, manufacture them, launch them, operate the network, and collect recurring service revenue long after the rockets leave the launch pad.
Iridium fills an important gap in Rocket Lab’s business. It brings a mature global communications network, licensed spectrum, long-term government relationships, and recurring cash flow that continues long after a satellite reaches orbit.
Granted, integrating an $8 billion acquisition carries execution risk. Rocket Lab must successfully close the transaction, integrate operations, manage its financing, and bring Neutron into commercial service on schedule. Those are meaningful challenges for any company.
Still, the strategic direction is becoming much clearer.
Key Takeaway In short, Rocket Lab is evolving from a launch company into a full-service space infrastructure platform. The proposed $8 billion acquisition of Iridium gives it communications networks, recurring revenue, licensed spectrum, and deeper government relationships, while Neutron has the potential to lower future deployment costs by bringing launches in-house.
SpaceX showed that controlling both transportation to orbit and the services delivered from orbit creates lasting competitive advantages. If Rocket Lab executes on this strategy, shareholders may eventually view this acquisition not as an expansion of its launch business but as the moment it transformed into an integrated space platform capable of competing across the entire space economy.
If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:
- Join Stock Advisor for one year, with a 30-day money-back guarantee
- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list
- Read the analysis, decide for yourself, and trade through your own brokerage
Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Space stocks are catching a bid Monday morning after Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) unveiled a definitive agreement to acquire Iridium Communications (NASDAQ:IRDM) in a cash-and-stock deal carrying an enterprise value of approximately $8 billion. Rocket Lab stock is up 12% to $95 in early trading.
The deal validates consolidation across the satellite economy, and peers are riding the momentum. AST SpaceMobile (NASDAQ:ASTS) stock is up 10% to $78 and change, while Planet Labs (NYSE:PL) stock is up 10% to $29.90.
The rally cuts against a brutal stretch for the group. Rocket Lab stock had fallen 44% over the prior month, while Planet Labs stock was down 46% and AST SpaceMobile stock was down 45% over the same window. Today’s gains are starting to repair some of that damage.
Rocket Lab Buys Iridium in $8 Billion Vertical Integration Play Under the terms, Iridium holders will receive $54 per share, consisting of $27 in cash plus Rocket Lab common stock based on an exchange ratio with a collar banded from $67.50 to $112.50. Both boards have unanimously approved the transaction, which is expected to close in mid-2027.
The strategic logic is easy to understand. Rocket Lab gets a profitable, recurring-revenue satellite communications network with more than 2.55 million subscribers across government, defense, aviation, and maritime markets, plus globally coordinated L-band spectrum and direct-to-device capabilities. Iridium generated $871.7 million in revenue and $495 million of operational EBITDA in 2025.
To fund the cash portion, Rocket Lab secured a $3.6 billion 364-day senior secured bridge term loan commitment from Deutsche Bank and Wells Fargo. CEO Sir Peter Beck declared it “a defining moment for the space industry.”
AST SpaceMobile Adds Its Own Catalyst AST SpaceMobile has its own catalysts beyond the sector tape. The company said BlueBirds 8, 9 and 10 are now operational in orbit, with the next trio targeted to launch from Cape Canaveral in the first half of August. Production is now running through BlueBird 37.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
AST SpaceMobile is targeting roughly 45 satellites in orbit by year-end and expects an orbital launch every one to two months on average this year. Institutional positioning into the constellation build-out appears to be supporting the shares.
Planet Labs Rides the Sector Tape Planet Labs has no company-specific catalyst today. The Earth-observation operator is moving purely on sector enthusiasm as investors rotate back into space exposure following the Rocket Lab announcement. With Planet Labs stock still up 37% year to date, momentum traders appear willing to chase the bounce.
For context, the recent pullback in Rocket Lab put valuations within reach for buyers who had missed the original move. The deal gives bulls a renewed thesis: a fully vertically integrated launch, manufacturing, and communications operator with hard cash flow attached.
What to Watch The risks are real in these space stocks. Rocket Lab still needs Iridium stockholder approval and regulatory approvals, and a mid-2027 close leaves plenty of time for deal spreads to widen if the political or financing backdrop sours. Polymarket data showed traders pricing the daily direction of RKLB stock at a 96% probability of an up close, with the weekly range concentrated in the $88 to $96 band.
Overall, these are volatile, speculative names with high betas. For example, Rocket Lab carries a beta of 2.499 and AST SpaceMobile sits at 2.634, so investors should consider keeping their position sizes modest. Investors can watch for whether today’s gains hold into the close and how Iridium’s deal spread settles relative to the $54-per-share offer.
If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:
- Join Stock Advisor for one year, with a 30-day money-back guarantee
- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list
- Read the analysis, decide for yourself, and trade through your own brokerage
Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in INCY over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Key Takeaways ALB and SQM are gaining from higher lithium prices driven by EV and energy storage demand.Albemarle is boosting capacity, cutting costs and expanding conversion projects to lift volumes.SQM delivered strong lithium volumes and strengthened its Atacama future via a Codelco partnership. Albemarle Corporation (ALB - Free Report) and Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) are prominent players in the lithium space. Both are well-placed to benefit from higher lithium prices driven by strong demand from electric vehicles (EVs) and energy storage systems, along with supply disruptions partly due to supply reductions in China. Lithium prices have rebounded from the trough levels seen last year, supported by tightening supply and strong demand in China and globally.
Let’s dive deep and closely compare the fundamentals of these two major lithium stocks to determine the better investment option now.
The Case for ALBAlbemarle is well-placed to gain from long-term growth in the battery-grade lithium market. The market for lithium batteries and energy storage remains strong, especially for EVs, offering significant opportunities for the company to develop innovative products and expand capacity. Lithium demand is expected to grow on the back of significant global EV penetration.
ALB expects lithium demand to witness a compound annual growth rate (CAGR) of 10-20% from 2025 to 2030. Stationary storage is expected to be a significant driver for lithium demand along with EVs. Albemarle expects demand to grow roughly 15-40% this year. Demand indicators stayed positive in the first quarter of 2026, with global Energy Storage Systems production rising 117% year over year.
The company is strategically executing its projects aimed at boosting its global lithium conversion capacity. It remains focused on investing in high-return projects to drive productivity. Healthy customer demand, capacity expansion and plant productivity improvements are supporting its volumes. ALB saw higher sales volumes (up 14% year over year) in its Energy Storage unit in the first quarter on the strength of its integrated conversion facilities.
The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes. ALB has started the environmental permitting process for a commercial direct lithium extraction project at Salar de Atacama. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule.
Albemarle is taking aggressive cost-saving and productivity actions. The company delivered roughly $450 million in cost and productivity improvements for full-year 2025, having surpassed its initial target of $300-$400 million. It expects additional cost and productivity improvements of $100-$150 million in 2026, with $40 million already delivered this year. ALB is taking actions to maintain its competitive position, including the initiation of a comprehensive review of cost and operating structure, optimization of the conversion network and reduction of capital expenditure.
Albemarle remains committed to driving shareholder value by leveraging healthy cash flows and strong liquidity. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from the prior-year period. At the end of the first quarter, ALB had liquidity of around $2.7 billion, including cash and cash equivalents of around $1.1 billion. ALB generated an operating cash flow of $346 million and free cash flow of $248 million in the quarter.
The company paid down $1.3 billion of outstanding debt in March 2026, reducing annual interest expense by roughly $60 million. This followed the successful divestments of the controlling stake in Ketjen and its 50% interest in the Eurecat joint venture, which together generated $670 million in pre-tax proceeds.
The company remains focused on maintaining its dividend payout. It has raised its quarterly dividend for the 30th straight year. ALB offers a dividend yield of 1.2% at the current stock price.
The Case for SQMChile-based Sociedad Quimica produces plant nutrients, iodine, lithium and industrial chemicals. SQM is gaining from the favorable trends in the lithium market underpinned by strong EV sales. Higher demand is expected to continue to support the company’s lithium sales volumes.
SQM logged strong lithium sales volumes of 69,000 metric tons in the first quarter on strong market demand, driven by battery energy storage systems. The Nova Andino Litio business recorded roughly 19% higher volumes compared to the prior-year quarter, driven by capacity expansion actions, and the company expects continued sequential increase.
Nova Andino Litio’s average realized sales price increased roughly 95% year over year in the first quarter, and it expects prices to increase further in the second quarter. SQM is operating at full capacity at the Mt. Holland mine and concentrator in Australia and continues to ramp up the Kwinana refinery.
SQM projects global lithium demand to surpass 1.9 million metric tons of LCE this year, along with a tight supply-demand balance. It raised its sales volume guidance for 2026, increasing expected volume growth from 10% to 15%.
Earlier this year, SQM and Codelco completed their strategic partnership to jointly develop the Atacama salt flat. The partnership was completed through the merger by absorption of Codelco’s subsidiary, Minera Tarar SpA, into SQM’s subsidiary, SQM Salar SpA.
This major milestone paves the way for the production of refined lithium in the Salar de Atacama until 2060 and contributes to making Chile a leader in lithium production. Improvements in process efficiency, the adoption of new technologies and the optimization of operations are expected to lead to incremental lithium production through 2060. The first quarter marked SQM’s first full quarter of operation alongside Codelco through the Nova Andino Litio partnership.
Sociedad Quimica’s robust balance sheet supports its capital investment in growth projects and shareholder-friendly actions. It exited the first quarter with strong liquidity, with cash and cash equivalents of around $2.8 billion. Sociedad Quimica, in early December 2025, issued a hybrid bond for roughly $430 million to refinance debt and fund its investment plan. SQM offers a dividend yield of 3.7% at the current stock price.
ALB & SQM: Price Performance, Valuation & Other ComparisonsThe ALB stock has surged 113.3% over the past year, while SQM has rallied 102.9%.
Image Source: Zacks Investment Research
ALB is currently trading at a forward price-to-sales ratio of 2.52. SQM is currently trading at a forward price-to-sales ratio of 2.41, slightly below ALB.
Image Source: Zacks Investment Research
ALB’s long-term debt-to-capitalization is around 15.2%, lower than SQM’s 36.8%.
Image Source: Zacks Investment Research
How the Zacks Consensus Estimate Compares for ALB & SQMThe Zacks Consensus Estimate for ALB’s 2026 sales implies year-over-year growth of 18.2%. The same for EPS suggests a 1,743% year-over-year rise. The EPS estimates for 2026 have been trending higher over the past 60 days.
Image Source: Zacks Investment Research
The consensus estimate for SQM’s 2026 sales and EPS implies a year-over-year rise of 80.2% and 251.9%, respectively. The EPS estimates for 2026 have been trending northward over the past 60 days.
Image Source: Zacks Investment Research
ALB or SQM: Which Stock Holds the Edge?ALB and SQM stand to benefit from higher lithium prices driven by EV and energy storage demand. Albemarle is benefiting from higher lithium volumes on project ramp-ups and actions to boost global lithium conversion capacity and productivity. SQM is delivering strong lithium volumes, expanding operations and is expected to benefit from the strategic partnership with Codelco.
ALB's higher earnings growth projections suggest that it may offer better investment prospects in the current market environment. Its lower leverage also suggests lower financial risks. Investors seeking exposure to the lithium space might consider Albemarle as the more favorable option at this time.
ALB currently carries a Zacks Rank #1 (Strong Buy), while SQM has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.
Dynatrace (DT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Silver is approaching what many technical traders would describe as a make-or-break moment. After a sharp rally over the past two years, the precious metal has retreated to a long-term rising trendline that has supported its bull market since early 2024.
The logo of Italian energy company Eni is seen on a booth stand during the Nigeria International Petroleum Summit in Abuja, Nigeria February 11, 2020. Picture taken February 11, 2020.... Purchase Licensing Rights, opens new tab Read more
CompaniesDUBAI, June 29 (Reuters) - Abu Dhabi's XRG and Italy's Eni (ENI.MI), opens new tab have signed agreements with Argentina's state oil company YPF (YPFDm.BA), opens new tab to acquire minority stakes in three upstream blocks in the South American country, the two companies said in separate statements on Monday.
The blocks are connected to a major liquefied natural gas project that is set to advance Argentina's gas ambitions.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
XRG and Eni will each acquire a 32% stake in the blocks, while YPF will retain the remaining 36% shareholding.
The Meseta Buena Esperanza, Aguada Villanueva, and Las Tacanas blocks are part of the unconventional Vaca Muerta basin.
The three blocks are expected to play a key role in Argentina LNG, an upstream-midstream project targeting LNG capacity of 12 million tons per annum (mtpa).
The project is vital to Argentina and President Javier Milei, whose government needs to increase energy exports to bolster dollar reserves and build confidence in its ability to maintain a stable currency.
The upstream assets are expected to supply the gas volumes needed to feed floating LNG units, Eni and XRG said, without providing financial details.
XRG, the international investments arm of Abu Dhabi National Oil Company, was set up to hunt for acquisitions in natural gas, chemicals and energy solutions and has a target of 20 million to 25 million mtpa of LNG capacity by 2035.
Reporting by Federico Maccioni; Editing by Joe Bavier
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Key Takeaways Natural gas prices reached a 20-week high as LNG export flows and hotter forecasts lifted demand.Feed gas deliveries to nine major U.S. LNG terminals rose to 17.3 Bcf/d in June from 17.1 Bcf/d in May.EXE, RRC and GPOR offer direct exposure as heat, LNG demand and storage trends shape gas prices. Natural gas prices have climbed to a 19- to 20-week high as stronger liquefied natural gas (“LNG”) export flows and a hotter near-term weather outlook improve demand expectations. The move puts summer power demand, storage trends and export activity back at the center of the market narrative.
For now, investors may want to concentrate on natural gas-focused names such as Expand Energy (EXE - Free Report) , Range Resources (RRC - Free Report) and Gulfport Energy (GPOR - Free Report) , which offer more direct exposure to the commodity backdrop.
Heat-Driven Demand Supports Natural Gas PricesNatural gas prices strengthened last week as hotter weather forecasts boosted expectations for stronger demand. U.S. natural gas futures touched a 20-week high during the period, reaching about $3.44/MMBtu on June 25, before profit-taking ahead of contract expiration pulled prices lower on Friday. The rally reflected growing optimism that higher summer demand could tighten market conditions.
Warmer-than-normal weather expected through early July is likely to increase air-conditioning use across homes and businesses. Since gas-fired plants generate a large share of U.S. electricity, higher power demand typically lifts natural gas consumption. Forecasts also pointed to rising Lower 48 demand, including exports, over the coming weeks, providing additional support to natural gas prices.
Export Demand Adds Another TailwindStrong LNG exports are providing additional support to natural gas prices. Feed gas deliveries to the nine major U.S. LNG export terminals averaged 17.3 billion cubic feet per day (Bcf/d) in June, up from 17.1 Bcf/d in May. Higher exports reduce domestic supply and keep prices firm.
Part of the increase came from stronger flows to the Golden Pass LNG facility in Texas. Export activity also remained steady, although one U.S. LNG cargo originally headed to China was later redirected to South Korea, highlighting healthy overseas demand despite changing trade routes.
High Storage Levels May Limit Further GainsDespite recent price strength, natural gas inventories remain comfortably above normal. Working gas in storage totaled 2,835 Bcf for the week ended June 19 after a weekly build of 76 Bcf, indicating that supplies are still sufficient.
Storage levels were 152 Bcf above the five-year average, leaving inventories nearly 6% higher than usual for this time of the year. Unless hotter weather and stronger LNG exports significantly slow storage injections, the ample supply could limit further upside in natural gas prices.
What the Natural Gas Market Is SignalingNatural gas fundamentals have improved compared with the softer spring period. Stronger electricity demand from hot weather, healthy LNG exports and firmer futures prices have helped improve market sentiment and supported the recent rally.
However, the market is not free from risks. Above-average storage levels continue to provide a supply cushion, meaning that sustained price gains will likely depend on continued hot weather and strong export demand in the weeks ahead.
3 Natural Gas Stocks Worth a Closer LookExpand Energy: Expand Energy has emerged as the largest natural gas producer in the United States after completing the Chesapeake-Southwestern merger. With a strong footprint in the Haynesville and Marcellus basins, the company is well-positioned to benefit from rising natural gas demand fueled by LNG exports, growing AI and data-center power needs, EV adoption and broader electrification trends.
The Zacks Consensus Estimate for Expand Energy’s 2026 earnings per share indicates a 42.6% year-over-year improvement. The firm, with a Zacks Rank #3 (Hold), has a trailing four-quarter earnings surprise of roughly 4.1%, on average. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Range Resources: Range Resources is a pure-play Appalachian producer focused on natural gas, with a leading position in the Marcellus shale supported by decades of high-quality inventory. Its operations emphasize efficient development of contiguous acreage, enabling low-cost production and durable free cash flow. The company benefits from diversified market access, supplying natural gas and liquids to domestic, LNG and international demand centers.
Range Resources beat the Zacks Consensus Estimate for earnings in each of the last four quarters. The natural gas producer, currently a #3 Ranked stock, has a trailing four-quarter earnings surprise of roughly 14.3%, on average.
Gulfport Energy: Gulfport Energy is a natural gas-weighted E&P company with core operations in the Utica and Marcellus shales, complemented by SCOOP assets. Its portfolio emphasizes low-breakeven, high-return drilling inventory and diversified takeaway capacity to premium markets, including Gulf Coast LNG demand. The firm, with a Zacks Rank of 3, focuses on disciplined capital allocation, operational efficiency, and expanding inventory through acquisitions and delineation.
The Zacks Consensus Estimate for the company’s 2026 earnings per share indicates 28.7% year-over-year growth. Gulfport Energy has a market capitalization of nearly $3 billion.
OAKLAND, Calif.--(BUSINESS WIRE)--Marqeta, Inc. (NASDAQ: MQ), the modern card issuing platform, previously announced that it will effect a 1-for-4 reverse stock split of all of Marqeta's outstanding shares of Class A Common Stock, Class B Common Stock, and Preferred Stock (the “Reverse Stock Split”). The Reverse Stock Split was approved by Marqeta's stockholders at the Company's annual meeting held on June 10, 2026, and will become legally effective at 4:00 p.m. Eastern Time on June 30, 2026. B.
Financial independence rarely arrives with a parade. For many people, it shows up on a Tuesday morning when someone else is scrubbing the bathroom. Hiring a cleaning service is a luxury many retirees and busy professionals buy, not just because they hate cleaning, but because it converts money into time. A housekeeper does more than clean a home. They return hours that can be spent with family, pursuing hobbies, traveling, volunteering, or simply enjoying retirement. This article calculates how much capital it takes to fund that freedom indefinitely without touching principal.
Things to Consider Before Hiring a Housekeeper If you’ve never spent money on domestic help, here are a few things to consider:
How much service do you need? Some people hire a cleaning service only a few times a year for deep cleaning. Others find that twice-monthly visits handle the most unpleasant chores without the cost of weekly service. Are you comfortable with the arrangement? Trust, privacy, scheduling, pets, and securing valuables are all worth considering. Check references and ask questions until you’re comfortable inviting someone into your home. What are you giving up? Money spent on housekeeping could instead fund travel, charitable giving, healthcare, or additional investing. Compare the cost of outsourcing housework against your other priorities. How will you use the extra time? The value comes from what replaces the chores, whether that’s family time, hobbies, exercise, volunteering, travel, or simply getting more rest. If the freed-up hours disappear into mindless scrolling and television, well, consider picking up a broom yourself instead. Three Service Tiers, Four Yield Levels Price the service before sizing the portfolio. Three realistic tiers cover most households:
Light service (twice-monthly cleaning): roughly $3,000 per year. Moderate service (weekly cleaning): roughly $6,000 per year. Premium service (weekly cleaning plus periodic deep cleans): roughly $12,000 per year. Divide the annual cost by the yield to get the capital required.
Service 3.5% yield 5% yield 7% yield 10% yield Light ($3K) $85,700 $60,000 $42,900 $30,000 Moderate ($6K) $171,400 $120,000 $85,700 $60,000 Premium ($12K) $342,900 $240,000 $171,400 $120,000 The 10-year Treasury is near 4.5%, so anything below that is paying you less than risk-free money. That is your reference point.
Where Each Tier of Yield Lives Conservative (3% to 4%), dividend-growth equities and utilities. Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) yields about 2.2% at $228 with 64 consecutive years of increases. Procter & Gamble (NYSE:PG) yields roughly 2.8% and just logged its 70th consecutive annual hike. NextEra Energy yields near 2.7% and guides about 10% dividend growth through 2026, then 6% through 2028. Broad dividend-growth ETFs and investment-grade bonds round out this bucket.
Moderate (5% to 7%), REITs, preferred shares, high-dividend equity funds. Realty Income (NYSE:O) trades at $60 with a 5.2% yield, paying $0.2705 monthly against 114 consecutive quarterly increases. Vanguard’s REIT index and the iShares preferred index sit in similar yield territory. Dividend growth slows here; inflation protection thins.
Aggressive (8% to 14%), BDCs, mortgage REITs, high-yield credit. Main Street Capital (NYSE:MAIN) pays a $0.26 monthly dividend plus a $0.30 quarterly supplemental, running near 6% on regulars and into the 8%+ range with supplementals. OneMain Holdings yields about 7.3%, but its net charge-off ratio ran about 8% in Q1, which is exactly the credit-cycle risk you absorb to get the coupon.
The Compounding Tradeoff Most Income Investors Miss Compare two portfolios sized to cover weekly cleaning today.
Portfolio A: $171,400 yielding 3.5% with 7% annual dividend growth. Year one income: $6,000. Year ten: about $11,800. Year twenty: about $23,200. By year ten the same portfolio is paying for the housekeeper and the lawn service.
Portfolio B: $60,000 yielding 10% with no growth. Year one income: $6,000. Year twenty: still $6,000, against a CPI that has been climbing steadily to 334. The cleaner’s invoice will not be.
When This Is the Wrong Use of Income If your withdrawal rate is already stretched, $6,000 a year is a real hole in the budget. If you genuinely enjoy housework or find the activity physically beneficial, the math changes. If you are still funding children, healthcare premiums, long-term care reserves, or other major priorities, those expenses should usually come first. And if paying for a housekeeper requires working extra hours at a job you dislike, it may be worth asking whether buying back time is actually improving your life or simply creating a different obligation.
Three Things to Do This Week Call two local services and price your actual square footage and frequency. Many readers discover they need closer to $3,000 a year than $12,000. Pull a 10-year total return comparison of a dividend-growth name like P&G against a high-yield BDC like Main Street. The compounding gap is the story. Run the tax map. Realty Income and Main Street distributions are largely ordinary income; qualified dividends from JNJ, P&G, and NextEra are taxed at preferential rates, which can shift the after-tax winner by an entire tier.
MCLEAN, VA / ACCESS Newswire / June 29, 2026 / Gladstone Investment Corporation (NASDAQ:GAIN) ("Gladstone Investment") announced today that it has entered into a definitive agreement to acquire Extrude Hone, an Irwin, Pennsylvania-based company. Extrude Hone is a leading provider of precision surface-finishing solutions used in mission-critical applications such as aerospace, automotive, heavy industrial, energy and other demanding end markets. The company's proprietary technologies and service capabilities help customers improve product performance, reliability and manufacturing efficiency.
Extrude Hone represents another example of Gladstone Investment's focus on partnering with established lower middle market businesses that hold leading positions in specialized industrial niches. Extrude Hone has built a strong reputation for technical expertise, long-standing customer relationships and mission-critical manufacturing solutions across a diverse set of end markets.
"We are excited to partner with the Extrude Hone management team and support the company's next phase of growth," said Christopher Lee, Executive Vice President of Gladstone Investment. "Extrude Hone has developed a strong market position, differentiated capabilities and a long history of serving customers with highly engineered finishing solutions. We look forward to investing alongside management to build upon that foundation."
"This definitive agreement to acquire Extrude Hone positions us to close on the acquisition subject to a final approval by regulatory authorities. We are pleased that the acquisition will add another quality company to Gladstone Investment's portfolio of operating businesses. We expect it to produce both income for dividends to shareholders and longer-term appreciation for capital gains," said David Dullum, Chief Executive Officer and President of Gladstone Investment.
Gladstone Investment is a publicly traded business development company that seeks to make equity and secured debt investments in lower middle market businesses in the United States in connection with acquisitions, changes in control and recapitalizations. Additional information on the transaction can be found at www.gladstoneinvestment.com.
For Investor Relations inquiries related to any of the monthly dividend paying Gladstone funds, please visit www.gladstone.com.
Forward-looking Statements:
The statements in this press release regarding the longer-term prospects of Gladstone Investment, Extrude Hone, and their management teams, and the ability of Gladstone Investment and Extrude Hone to grow and expand are "forward-looking statements." These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on Gladstone Investment's current plans that are believed to be reasonable as of the date of this press release, a number of factors could cause actual results and conditions to differ materially from these forward-looking statements, including those factors described from time to time in Gladstone Investment's filings with the Securities and Exchange Commission. Gladstone Investment undertakes no obligation to update or revise these forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.
For further information: Gladstone Investment Corporation, (703) 287-5893
Interparfums (IPAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Match Group (MTCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SAN RAMON, Calif.--(BUSINESS WIRE)--Five9, Inc. (NASDAQ: FIVN) (“Five9” or the “Company”), provider of the Intelligent CX Platform, today announced the appointments of Niranjan Vijayaragavan as Five9's new Chief Technology Officer, Rob Hornish as its new Chief Sales Officer, and Sven Linsmaier as Executive Vice President, Transformation and Strategy, effective June 29, 2026. These executive team updates come as Five9 continues to scale its AI-driven CX strategy and sharpen execution across the.
First published data evaluating gene-editing treatment in children ages 5-11 with inherited blood disorders highlights the potential for earlier intervention before cumulative injury
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia.
Sickle cell disease and beta thalassemia are inherited blood disorders that can cause serious, lifelong complications beginning in childhood. A therapy that works in children ages 5-11 could make earlier intervention possible, potentially treating these diseases before years of cumulative injury and treatment burden occur.
The study's lead author, Dr. Haydar Frangoul, medical director of HCA Healthcare’s Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Children's Hospital, presented the first published data evaluating exagamglogene autotemcel (exa-cel) in children ages 5-11. The study was conducted in collaboration with Sarah Cannon Research Institute.
"For many patients with sickle cell disease and beta thalassemia, the burden of disease begins early in life," said Dr. Frangoul. “These findings reinforce the promise of gene-editing therapy and underscore the importance of continuing rigorous clinical research to evaluate new treatment options for children and individuals affected by these serious blood disorders."
According to the Centers for Disease Control and Prevention, sickle cell disease affects approximately 100,000 people in the United States and is the nation's most common inherited blood disorder. Children with sickle cell disease can experience severe pain crises, organ damage and frequent hospitalizations. Severe beta thalassemia affects thousands of people in the United States, and children with the condition often require lifelong blood transfusions that can lead to significant health complications.
The study evaluated exa-cel, a CRISPR-based cell therapy, which is currently approved by the U.S. Food and Drug Administration for eligible patients ages 12 and older with sickle cell disease and transfusion-dependent beta thalassemia. The therapy is designed to work by editing a patient's own blood-forming stem cells to increase production of fetal hemoglobin, which can help prevent or reduce disease complications. Participants underwent myeloablative conditioning, a conditioning chemotherapy treatment used to prepare the bone marrow to receive modified stem cells.
The findings were based on two phase 3 studies that enrolled 26 children ages 5-11, including 15 with transfusion-dependent beta thalassemia and 11 with sickle cell disease. Among participants who had been followed long enough to evaluate the study's primary endpoints, all eight children with beta thalassemia achieved transfusion independence for at least 12 months, while all eight children with sickle cell disease remained free from severe vaso-occlusive crises for at least 12 months.
"Studies like this demonstrate the important role research plays in advancing medicine and expanding treatment possibilities for patients," said Dr. Michael Cuffe, executive vice president and chief clinical officer of HCA Healthcare. “Through the HCA Healthcare Research Institute and in collaboration with the Sarah Cannon Research Institute, we are helping develop new therapies and treatment possibilities for patients facing serious and complex diseases."
The current NEJM study builds on HCA Healthcare's leadership in cell and gene therapy research and the pioneering work conducted at TriStar Centennial Medical Center, a part of the Sarah Cannon Transplant and Cellular Therapy Network. Across the network, more than 1,600 blood and marrow transplants and cellular therapies are performed annually. Dr. Frangoul was previously an investigator in the first U.S. clinical trial to use gene-editing to treat sickle cell disease, contributing to the development of the first FDA-approved CRISPR-based therapy in the U.S. for patients ages 12 and older. Like the previous CRISPR gene-editing clinical trial, the current NEJM study is sponsored by Vertex Pharmaceuticals Incorporated. In 2026 alone, Dr. Frangoul has authored five gene-editing studies published in NEJM.
Building on this research, HCA Healthcare’s Sarah Cannon Transplant and Cellular Therapy Network is expanding access to FDA-approved gene-editing therapies through specialized transplant and cellular therapy programs. TriStar Centennial Children's Hospital in Nashville and Methodist Children's Hospital in San Antonio currently offer gene-editing therapies for eligible patients, with Medical City Children's Hospital in Dallas preparing to expand services.
The full study is available on The New England Journal of Medicine website.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 47 million annual patient encounters to advance science, improve patient care and save lives.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
Q2 Holdings (QTWO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
